152 Episodo

  1. CNS Summit Series: Patient-Centric Innovation at Scale, with Cristina Duran of Evinova

    Publicado: 5/12/2024
  2. CNS Summit Series: Celebrating 15 Years of Innovation with Dr. Amir Kalali of CNS Summit

    Publicado: 3/12/2024
  3. Project Optimus Series: Navigating the Realities of Project Optimus

    Publicado: 26/11/2024
  4. Psychedelics 3.0: Challenges and Opportunities in an Evolving Field

    Publicado: 30/10/2024
  5. A Site-Specific Approach to Optimizing Diversity in Oncology Trials

    Publicado: 23/10/2024
  6. Circulating Tumor DNA: Transforming Oncology Clinical Trials

    Publicado: 2/10/2024
  7. Cashing in on the Currency of Information

    Publicado: 24/9/2024
  8. Decoding Gen AI’s Potential to Drive More Effective Clinical Trials

    Publicado: 21/8/2024
  9. Connecting the Global Dots on Carbon Footprint in Biopharma

    Publicado: 9/7/2024
  10. Can AI Help Get the Right Patients Into Alzheimer's Clinical Trials?

    Publicado: 31/5/2024
  11. Unpacking the Role of Adjuvant Therapies in Breast Cancer

    Publicado: 23/5/2024
  12. Site and Study Execution for Ophthalmology Trials

    Publicado: 8/5/2024
  13. The Case for Genetic Medicines

    Publicado: 29/4/2024
  14. Jeff Stewart Says Goodbye

    Publicado: 23/4/2024
  15. Patient Assistance: The Best Deal in Pharma

    Publicado: 23/4/2024
  16. Real Talk About the Inflation Reduction Act

    Publicado: 17/4/2024
  17. Turbo-Charging Clinical Trials

    Publicado: 2/4/2024
  18. Investing for Commercial Success as an Emerging Company

    Publicado: 6/3/2024
  19. Ophthalmology Clinical Trials: Low Vision and AMD Awareness Month

    Publicado: 16/2/2024
  20. FDA Rules for Radio & TV Advertising

    Publicado: 30/1/2024

1 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site